DUBLIN, July 13, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zf38r3/cardiac) has announced the addition of the "Cardiac Monitoring & Cardiac Rhythm Management Market ECG, Implantable Loop Recorder, Manual Event Monitor, Cardiac Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Forecasts to 2020" report to their offering.
The global cardiac monitoring and cardiac rhythm management devices market is poised to reach $26,646.5 Million by 2020 from $21,137.7 Million in 2015, at a CAGR of 4.7% from 2015 to 2020.
Major factors fueling market growth are increasing incidences of cardiovascular diseases, launch of technologically advanced products in mobile cardiac telemetry, and emergence of private institutional nursing and home care. However factors such as dearth of skilled healthcare professionals with expertise in electrocardiography and cardiac monitoring; and pressure to contain healthcare costs hampering complete adoption of advanced technologies are expected to restrain the growth of the CM and CRM devices market.
On the basis of products, Cardiac Monitoring devices segment is categorized into electrocardiogram (ECG) devices, event monitors, implantable loop recorders (ILR), and cardiac output monitoring (COM) devices. The ECG devices segment is expected to account for the largest share in 2015 and will be the fastest-growing product segment during the forecast period. The cardiac rhythm management devices segment is categorized into defibrillators, pacemakers, and cardiac resynchronization therapy (CRT) devices. The defibrillator segment is expected to account for the largest share in 2015. The defibrillator segment will also be the fastest-growing product segment during the forecast period. Major factors contributing to the growth of the market are increasing incidences of CVD, and technological advancements.
The major end users of cardiac monitoring and cardiac rhythm management devices include home/ambulatory settings, hospitals, and other end users (research institutes and laboratories). The home/ambulatory settings segment is expected to account for largest share in 2015. Similarly Home/Ambulatory settings segment will be the fastest-growing segment during the forecast period owing to increasing preference of mobile telemetry devices at the home/ambulatory settings.
Geographically, the cardiac monitoring and cardiac rhythm management devices market is dominated by North America, followed by Europe. The market in Asia is expected to grow at a highest CAGR during the forecast period. Rise in cardiovascular diseases, and technological advantage such as mobile cardiac telemetry are major drivers of this market.
Key players operating in the cardiac monitoring and cardiac rhythm management devices market are Medtronic Inc. (U.S.), GE Healthcare (U.K.), Boston Scientific Inc. (U.S.), Philips Healthcare (The Netherlands), St. Jude Medical Inc. (U.S.)
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cardiac Monitoring Market, By Product
7 Crm Devices Market, By Product
8 Cardiac Monitoring And Cardiac Rhythm Management Market, By End Users
9 Cardiac Monitoring And Cardiac Rhythm Management Market, By Region
10 Competitive Landscape
11 Company Profiles
For more information visit http://www.researchandmarkets.com/research/zf38r3/cardiac
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets